- Programs & Services
- Cost Management
- Specialty Management
- Care Management
- Member Engagement
- Health Plan Client Engagement
2021 Oncology Symposium
On May 26, 2021, CVS Health was pleased to host a first-of-its-kind Oncology Symposium. A diverse group of leading experts shared the latest thinking on components of oncology cost and care that collectively help meet the quadruple aim for oncology management. Addressing key issues of concern for plan oncology managers and other stakeholders, the speakers highlighted promising concepts and potential solutions.
Working with the oncology community, CVS Health can make the process better, make the experience better and make care better. We are focused on improving cancer care for patients and providers through tools such as digital connectivity that are designed to make it easier to administer care.
From the latest on pipeline oncology therapies, to new evidence for treatment guidelines, to the latest in gene sequencing, the symposium provided an overview of the current oncology management landscape. Video recordings of the presentations are available below.
Cancer survival rates are increasing; mortality has declined by 20 percent since 1950. But with an average treatment cost of $150,000 or more and average out-of-pocket costs topping $15,000, cancer patients are 2.5 times more likely to declare bankruptcy.
https://www.aarp.org/money/credit-loans-debt/info-2018/the-high-cost-of-cancer-treatment.html https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778988/ More
VIDEO — Shirisha Reddy, MD, Medical Director, Enterprise Oncology Solutions, CVS Health
The National Comprehensive Cancer Network (NCCN) is a nonprofit coalition of 31 leading academic cancer centers that develops the NCCN Clinical Practice Guidelines. A total of 81 NCCN Guidelines feature 206 algorithms that apply to 97 percent of US cancer cases. More
VIDEO — Wui-Jin Koh, MD, CMO, NCCN
Many cancer treatments today are the result of “thoughtful empiricism,” in which different drugs or different combinations of drugs are used to halt unregulated cell growth. But cancer is a disease of the genome. More
VIDEO — Brian Alexander, MD, MPH, CEO, Foundation Medicine
What cancer patients want is choice and a more active voice in their care. More than half are looking for additional emotional and clinical support during treatment. More
VIDEO — Christine Sawicki, Rph, Senior Director, CVS Health
One of the most effective cost containment strategies used by payors are site of care restrictions. Now that infusions can be performed outside of the hospital, there are creative ways to solve the problem of site of care restrictions. More
VIDEO — Linde Wilson, Chief Strategy Officer, Cancer Treatment Centers of America